drugset / Trial / NCT00887770
A Study to Investigate the Potential for AZD5672 to Affect the Electrical Conduction Pathways in the Heart
RandomizedCrossoverTriple-blindBasic science
Summary
This study is being performed to investigate the potential for AZD5672 to affect the electrical conduction pathways in the heart. AZD5672 will be compared against a drug (moxifloxacin - a licensed antibiotic) known to have a detectable but safe change on the electrical conduction of the heart.
Timeline
- Start
- 2009-04
- Primary completion
- —
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD5672 | Small molecule | 150 mg | Oral |
| Subject | AZD5672 | Small molecule | 600 mg | Oral |
| Comparator | Moxifloxacin | Small molecule | 400 mg | Oral |